首页> Open heart> Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience.

Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience.

导出 LinkOut

翻译打印收藏纠错

第一作者： Akshee,Batra

第一单位： Department of Medicine, University of Vermont Medical Center, Burlington, Vermont, USA.

作者： Akshee,Batra ^[1] ; Brijesh,Patel ^[2] ; Daniel,Addison ^[3] ; Lauren A,Baldassarre ^[4] ; Nihar,Desai ^[4] ; Neal,Weintraub ^[5] ; Anita,Deswal ^[6] ; Zeeshan,Hussain ^[7] ; Sherry-Ann,Brown ^[8] ; Sarju,Ganatra ^[9] ; Vivek,Agarwala ^[10] ; Purvish M,Parikh ^[11] ; Michael,Fradley ^[12] ; Arjun,Ghosh ^[13] ; Avirup,Guha ^[14]

作者单位： Department of Medicine, University of Vermont Medical Center, Burlington, Vermont, USA. ^[1] Department of Cardiology, West Virginia University, Morgantown, West Virginia, USA. ^[2] Cardio-Oncology Program, Division of Cardiology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA. ^[3] Department of Cardiology, Yale School of Medicine, New Haven, Connecticut, USA. ^[4] Cardio-Oncology Program, Division of Cardiology, Department of Internal Medicine, Augusta University Medical College of Georgia, Augusta, Georgia, USA. ^[5] Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[6] Harrington Heart and Vascular Institute, University Hospitals, Cleveland, Ohio, USA. ^[7] Medical College of Wisconsin, Milwaukee, Wisconsin, USA. ^[8] Department of Cardiovascular Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts, USA. ^[9] Department of Medical Oncology, Narayana Superspeciality Hospital-Howrah, Howrah, West Bengal, India. ^[10] Mumbai Oncocare Centers, Mumbai, Maharashtra, India. ^[11] Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. ^[12] Barts and The London NHS Trust, London, UK. ^[13] Cardio-Oncology Program, Division of Cardiology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA avirup.guha@gmail.com.;Cardio-Oncology Program, Division of Cardiology, Department of Internal Medicine, Augusta University Medical College of Georgia, Augusta, Georgia, USA.;Department of Internal Medicine, Case Western Reserve University, Cleveland, Ohio, USA. ^[14]

关键词 drug monitoring epidemiology healthcare outcome assessment